Leonard S. Schleifer, President & CEO at REGENERON PHARMACEUTICALS INC (REGN), sold 3,453 shares at $400.11 ($1.4M) on 2014-10-31, disclosed to the SEC on 2014-11-04.
Scheduled sale ($1.4M) by President & CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| REGN | SELL | 2024-05-17 | $44.7M | — | Filing → |
| REGN | SELL | 2024-05-15 | $70.1M | — | Filing → |
| REGN | SELL | 2022-04-07 | $10.1M | — | Filing → |